On the other hand, SOCS2 acts as an oncogene in advanced stages of chronic myeloid leukemia as well as in precursors of anal cancer, where it is significantly upregulated (Arany et al. 2001, Schultheis et al. 2002). This evidence concerns the gene SOCS2 and chronic myelogenous leukemia, BCR-ABL1 positive.